BIO-ME AS

Operating

Utvikling, markedsføring og salg av diagnostiske tester, inkludert programvare og opplæring, og tilstøtende tjenester og ytelser.

Tilby diagnostisk test som service og som kit, og relaterte produkter og tjenester.

Keywords

physicalchemicalanalytical testingmaterialsproductsacoustic testingvibration testingcompositionpurityfood hygieneveterinary controlperformance testingtype approvalcertificationclassification

Organization

CEO: WG
Warren George Rubottom Flood1985
Chairman of the board: CC
Carl Christian Gilhuus-Moe1944
Years since formation: 10 years; since Jun 16, 2016
Type: Limited company
VAT registered: Yes
Number of employees: 9

Ownership

Number of shares and share classes: 4,830,355; 1 share class
Total number of shareholders: 56; 27 companies, 29 persons

Financials

Total operating income 2024: 9,179,107; NOK
Annual total result 2024: -8,965,768; NOK
Total equity 2024: 3,342,955; NOK

Last update: Dec 12, 2025

Locations

Forskningsparken Gaustadalléen 21 0349 OSLO, Norge

Company address
Forskningsparken Gaustadalléen 21 0349 OSLO, Norge
Copied!
Postal address
Postbpks 8600 Majorstuen 0349 OSLO, Norge
Copied!

Management

Management / administration

Name	Role	Shares
WG Warren George Rubottom Flood 1985	Managing Director/CEO	1.89 % directly

Board

Name	Role	Shares
CC Carl Christian Gilhuus-Moe 1944	Chairman	-
SC Sverre Christian Munck 1953	Board Member	2.54 % indirectly
AM Anne Marie Duus Kristensen 1965	Board Member	-
AC Arne Christian Materna 1976	Board Member	-

Others

Name	Role	Shares
A AKERSHUS REVISJON AS	Auditor	-
E ESCALON SERVICES NORWAY AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
PL Pauline Lynne Isaksen 1958	-	8.75 % indirectly
ML Morten Ludvik Isaksen 1961	-	8.75 % indirectly
IF Inger Frydenlund Bugge 1944	-	6.07 % directly 1.55 % indirectly 4.52 %
HL Helge Lund 1962	-	5.38 % indirectly
AH Arild Herman Blixrud 1944	-	4.14 % directly
TR Trond Riiber Knudsen 1964	-	3.61 % indirectly
CB Charles Bernhard Stabell 1943	-	3.6 % indirectly
PR Peder Røhne Figenbaum 1973	-	3.26 % indirectly
MR Marianne Røhne Figenbaum 1977	-	3.26 % indirectly
SC Sverre Christian Munck 1953	Board Member	2.54 % indirectly

Last update: Sep 24, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
P PTI SOLUTIONS AS	Ordinary shares	845,000	17.49 %
IA Invest Aps Ebdus	Ordinary shares	397,380	8.23 %
J JOHS. HANSEN & CO AS	Ordinary shares	353,096	7.31 %
I INKERMAN AS	Ordinary shares	325,000	6.73 %
A AS PARKGAARDEN HOLDING	Ordinary shares	218,333	4.52 %
I IDAS LOMME AS	Ordinary shares	212,833	4.41 %
AH Arild Herman Blixrud 1944	Ordinary shares	200,140	4.14 %
A ALEAP AS	Ordinary shares	193,023	4 %
K KATAPULT ACCELERATOR FUND 2 AS	Ordinary shares	175,157	3.63 %
S STABELL HOLDING AS	Ordinary shares	173,809	3.6 %
T TRK GROUP AS	Ordinary shares	172,976	3.58 %
L LIBRAS AS	Ordinary shares	122,982	2.55 %
ES Espen Stenersen 1984	Ordinary shares	108,680	2.25 %
AN Aps Nescon	Ordinary shares	108,333	2.24 %
MT Martin Thomas Isaksen 1987	Ordinary shares	100,000	2.07 %
I Invest4health	Ordinary shares	93,334	1.93 %
WG Warren George Rubottom Flood 1985	Ordinary shares	91,363	1.89 %
T TELEFONKIOSKEN AS Under liquidation	Ordinary shares	84,000	1.74 %
PG Peter Groth 1947	Ordinary shares	83,500	1.73 %
IF Inger Frydenlund Bugge 1944	Ordinary shares	75,000	1.55 %
C COREMED AS	Ordinary shares	54,333	1.12 %
LG Lars Gustav Snipen 1966	Ordinary shares	50,000	1.04 %
B BILLOD AS	Ordinary shares	45,590	0.94 %
HC Heidi Cecilie Vebø 1978	Ordinary shares	35,000	0.72 %
P PROCAP AS	Ordinary shares	34,667	0.72 %
HR Høgh Rasmussen Allan	Ordinary shares	31,500	0.65 %
WF William Frank Harris 1953	Ordinary shares	30,441	0.63 %
MF Mellentin Frederik	Ordinary shares	30,000	0.62 %
MG Maria Gjerstad Maseng 1993	Ordinary shares	25,809	0.53 %
F FJORDNES HOLDING AS	Ordinary shares	25,524	0.53 %
R RUNAR VIGE INVEST AS	Ordinary shares	25,500	0.53 %
R RINGKJØB EIENDOM AS	Ordinary shares	25,000	0.52 %
S STRAHLSUND AS	Ordinary shares	23,605	0.49 %
KN Kristina Nybo Isaksen 1982	Ordinary shares	22,684	0.47 %
KR Karl Robert Isaksen 1985	Ordinary shares	22,683	0.47 %
B BIO-ME AS	Ordinary shares	19,134	0.4 %
R RETRETT AS	Ordinary shares	17,100	0.35 %
E ELEMENTUM AS	Ordinary shares	15,566	0.32 %
H HEALTHCO HOLDING AS	Ordinary shares	15,000	0.31 %
NF Nicolai Færø Torgersen 1987	Ordinary shares	14,000	0.29 %
T TFM INVEST AS	Ordinary shares	12,500	0.26 %
F FUTURUM AS	Ordinary shares	12,000	0.25 %
FH Furberg Hilde	Ordinary shares	10,000	0.21 %
F FORBIS AS	Ordinary shares	10,000	0.21 %
SS Satya Sree Kuraganti 1985	Ordinary shares	10,000	0.21 %
B BOIGA AS	Ordinary shares	10,000	0.21 %
JA Jon Alm Eriksen 1984	Ordinary shares	10,000	0.21 %
FP Finzel Perez Ana	Ordinary shares	9,980	0.21 %
DS Duus Svensson Oskar	Ordinary shares	8,750	0.18 %
DS Duus Svensson Victor	Ordinary shares	8,750	0.18 %
A ANALOG CORE INVEST AS	Ordinary shares	7,000	0.14 %
MD Marie Duus Kristensen Anne	Ordinary shares	6,667	0.14 %
TS Tore Sagstuen 1973	Ordinary shares	6,333	0.13 %
KS Karttunen Sarah	Ordinary shares	5,600	0.12 %
JP Javier Pardo Fernandez 1997	Ordinary shares	4,200	0.09 %
LM Lucas Matheus Padilha Barros 1995	Ordinary shares	1,500	0.03 %

Shares owned by the BIO-ME AS

Name	Share class	Total number of shares	Share
B BIO-ME AS	Ordinary shares	19,134	0.4 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	9,179,107	7,352,689	5,650,202	3,112,616
Annual Total Result	-8,965,768	-10,226,224	-8,712,863	-6,862,817
Total assets	8,698,120	8,239,947	10,264,384	8,994,465
Total liabilities	5,355,165	5,529,388	5,368,602	4,327,740
Total equity	3,342,955	2,710,558	4,895,783	4,666,725

P&L

Year	2024	2023	2022	2021
Total operating income	9,179,107	7,352,689	5,650,202	3,112,616
Total operating costs	17,960,714	17,553,334	14,368,662	9,732,326
Operating result	-8,781,607	-10,200,645	-8,718,460	-6,619,711
Financial income/costs	-184,161	-25,579	5,597	-243,107
Profit before tax	-8,965,768	-10,226,224	-8,712,863	-6,862,817
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-8,965,768	-10,226,224	-8,712,863	-6,862,817

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	170,412	250,956	271,156	0
Total current assets	8,527,708	7,988,990	9,993,228	8,994,465
Total assets	8,698,120	8,239,947	10,264,384	8,994,465
Short term debt	3,605,165	5,529,388	2,968,602	1,927,740
Long term debt	1,750,000	0	2,400,000	2,400,000
Total liabilities	5,355,165	5,529,388	5,368,602	4,327,740
Contributed capital	4,477,288	2,710,558	4,895,783	4,666,725
Retained earnings	-1,134,333	0	0	0
Total equity	3,342,955	2,710,558	4,895,783	4,666,725
Total equity and liabilities	8,698,120	8,239,947	10,264,384	8,994,465

Classification

21st company classification

BETA

Scaleup

BIO-ME AS917 330 514

BIO-ME AS

Keywords

Links

Organization

Ownership

Financials

Locations

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the BIO-ME AS

Financials

Summary

P&L

Balance overview

Classification